Scroll to Content

OUR TECHNOLOGY

Healing Through Innovation

Reimagining the gold standard of Allograft tissue through a MIS approach. The science of biologic therapy continues to be the standard of care in treating patients across the majority of operative spinal pathologies. Through a novel, proprietary implant design and simple MIS instrumentation, the OsteoLif™ technique featuring OsteoPearl™ technology empowers physicians to provide scientifically proven regenerative solutions within pathologies that have been underrepresented due to limitations of technology.

OUR FOCUS

Vertebral Compression Fractures

Vertebral Body Augmentation involves surgical placement of an instrument to create a cavity within a fractured vertebral body, due to trauma or osteoporosis. When the cavity is created, a device is implanted to fill the void and provide stability to damaged vertebrae.

When a biologic is used to fill the cavity, a regenerative phenomenon occurs, new bone begins to grow – and a gradual healing of the affected vertebrae is achieved.

When a synthetic is used to fill the cavity, no healing occurs, and the epoxy is left in the patient's vertebrae. Even though the synthetic technique is widely used in industry, there are a variety of complications. First, the epoxy is known to migrate outside the defined cavity (~23%) predisposing the patient for risk of embolisms. Secondly, no healing occurs within the fractured vertebrae. Third, the vertebrae can no longer be instrumented with pedicle screws if/when the patient will need additional surgery. The inability to instrument a vertebrae, may result in a more invasive procedure with a myriad of complications and comorbidities. The time and temperature sensitivity of the epoxy, the toxic out-gassing, and numerous instrumentation also makes for an undesirable OR experience.

AREAS OF EXPLORATION

Ultra MIS | Awake TLIF | Endoscopic MIS

Surgeons and Industry are continuing to push the limits of MIS. Ultra MIS, Awake TLIF, Endoscopic MIS will continue to grow momentum.

Innovation continues to advance tissue sparing MIS techniques, however the challenge to maximize graft size continues to be an unmet need. Expandable cages have iterated over the years, and have not been shown to be a pure Ultra MIS solution, leaving surgeons having to choose a more invasive approach, or settle on a suboptimal interbody solution.